Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.
Laura Ann MageePeter Von DadelszenJoel SingerTerry LeeEvelyne ReySusan RossElizabeth V AsztalosKellie E MurphyJennifer Z MenziesJ Johanna SanchezAmiram GafniAndrée GruslinMichael HelewaEileen HuttonShoo K LeeAlexander Gordon LoganWessel J GanzevoortRoss WelchJames G ThorntonJean Marie MoutquinPublished in: Acta obstetricia et gynecologica Scandinavica (2016)
CHIPS data suggest that when women with chronic hypertension develop an elevated blood pressure in pregnancy, or formerly normotensive women develop new gestational hypertension, maternal and current pregnancy clinical characteristics cannot predict adverse outcomes in the index pregnancy.
Keyphrases
- blood pressure
- pregnancy outcomes
- pregnant women
- randomized controlled trial
- hypertensive patients
- preterm birth
- heart rate
- birth weight
- study protocol
- blood glucose
- emergency department
- clinical trial
- weight gain
- physical activity
- skeletal muscle
- big data
- weight loss
- deep learning
- glycemic control
- data analysis
- breast cancer risk
- arterial hypertension